Yoshika Tsuji

Nagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Smoking-associated IgG4-positive cell infiltration in rheumatoid arthritis lung: an exploratory cross-sectional study.

Smoking-associated IgG4-positive cell infiltration in rheumatoid arthritis lung: an exploratory cross-sectional study.

Journal: Frontiers in immunology

Published: May 06, 2026

Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy.

Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid Therapy.

Journal: Internal medicine (Tokyo, Japan)

Published: December 24, 2025

Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus.

Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus.

Journal: Frontiers in immunology

Published: February 05, 2025

M694I variant of MEFV drives pathogenesis of familial Mediterranean fever through enhanced Th17 cell differentiation.

M694I variant of MEFV drives pathogenesis of familial Mediterranean fever through enhanced Th17 cell differentiation.

Journal: Rheumatology (Oxford, England)

Published: February 01, 2025

The COVID-19 Pandemic Heightens Interest in Cytokine Storm Disease and Advances in Machine Learning Diagnosis, Telemedicine, and Primordial Prevention of Rheumatic Diseases.

The COVID-19 Pandemic Heightens Interest in Cytokine Storm Disease and Advances in Machine Learning Diagnosis, Telemedicine, and Primordial Prevention of Rheumatic Diseases.

Journal: European journal of rheumatology

Published: December 09, 2024

Efficacy and safety of canakinumab in familial Mediterranean fever in Japan: a single-centre retrospective study.

Efficacy and safety of canakinumab in familial Mediterranean fever in Japan: a single-centre retrospective study.

Journal: Clinical and experimental rheumatology

Published: August 14, 2024

Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.

Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab.

Journal: Modern rheumatology

Published: January 22, 2024

Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.

Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.

Journal: Clinical immunology (Orlando, Fla.)

Published: September 24, 2023

Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study.

Identification of risk factors for elevated serum IgG4 levels in subjects in a large-scale health checkup cohort study.

Journal: Frontiers in immunology

Published: December 15, 2022

VEXAS syndrome complicated with severe infection.

VEXAS syndrome complicated with severe infection.

Journal: Rheumatology (Oxford, England)

Published: March 05, 2022

Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis.

Real-world comparative effectiveness and safety of tofacitinib and baricitinib in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: February 18, 2021

Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.

Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease.

Journal: Clinical and experimental rheumatology

Published: August 11, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026